| Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer) (NCT01420874) | Barbara Ann Karmanos Cancer Institute | 2011-08-17 |
| To Investigate the Effect of Intravenous Ondansetron on Cardiac Conduction as Compared to Placebo and Moxifloxacin in Healthy Adult Subjects (NCT01449188) | GlaxoSmithKline | 2011-08-16 |
| The Effects of Bethanechol on Glucose Homeostasis (NCT01434901) | Washington University School of Medicine | 2011-08-15 |
| Humanized 3F8 Monoclonal Antibody (Hu3F8) in Patients With High-Risk Neuroblastoma and GD2-Positive Tumors (NCT01419834) | Memorial Sloan Kettering Cancer Center | 2011-08-15 |
| Hemodynamic Response of Neuropathic And Non-Neuropathic POTS Patients To Adrenoreceptor Agonist And Antagonist (NCT03070730) | Beth Israel Deaconess Medical Center | 2011-08-15 |
| Influenza Antiviral DAS-181-F04 in Healthy Adults (NCT01651494) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-08-12 |
| Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers (NCT01375699) | Virginia Commonwealth University | 2011-08-11 |
| LRRK2 Mutation and Parkinson's Disease (NCT01424475) | GlaxoSmithKline | 2011-08-11 |
| SSP-002358 Drug Interaction Study With Omeprazole (NCT01415349) | Shire | 2011-08-11 |
| Japanese Phase 1 Study of Mepolizumab (NCT01471327) | GlaxoSmithKline | 2011-08-09 |
| MLN8237 in Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Rituximab +/- Vincristine (NCT01397825) | Millennium Pharmaceuticals, Inc. | 2011-08-09 |
| A Study of Omarigliptin (MK-3102) in Participants With Impaired Renal Function (MK-3102-009) (NCT01407276) | Merck Sharp & Dohme LLC | 2011-08-08 |
| Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease (NCT01475162) | Medical College of Wisconsin | 2011-08-08 |
| Delanzomib (CEP-18770) in Combination With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma (NCT01348919) | Teva Branded Pharmaceutical Products R&D, Inc. | 2011-08-03 |
| BAY73-4506 Probe Substrate Study (NCT01287598) | Bayer | 2011-08-02 |
| Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies (NCT01421173) | M.D. Anderson Cancer Center | 2011-08-01 |
| Pharmacokinetic Study of Primaquine in Healthy Obese Thai Adult Subjects (NCT02789566) | University of Oxford | 2011-08-01 |
| Impact of Pretreatment With Metformin on Colorectal Cancer Stem Cells (CCSC) and Related Pharmacodynamic Markers (NCT01440127) | Tufts Medical Center | 2011-08-01 |
| Nilotinib With Radiation for High Risk Chordoma (NCT01407198) | Massachusetts General Hospital | 2011-08-01 |
| PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Histology (NCT01387711) | LEO Pharma | 2011-08-01 |
| Telemedicine Versus Traditional Treatment of Muscle Tension Dysphonia (NCT01419444) | University of Arkansas | 2011-08-01 |
| Intracerebral Gene Therapy for Sanfilippo Type A Syndrome (NCT01474343) | LYSOGENE | 2011-08-01 |
| Study of Neoadjuvant Carboplatin, Eribulin and Trastuzumab for Operable HER2 Positive Breast Cancer (NCT01388647) | Vector Oncology | 2011-08-01 |
| Investigation of the Effect of Dietary Nitrate Treatment on Endothelial Function and Platelet Reactivity in Hypercholesterolemics. (NCT01493752) | Queen Mary University of London | 2011-08-01 |
| Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma (NCT01404702) | University of Alabama at Birmingham | 2011-08-01 |
| Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years (NCT01364571) | Pfizer | 2011-08-01 |
| Safety and Pharmacokinetics of AT1001 (Migalastat HCl) in Healthy Subjects and Subjects With Impaired Renal Function (NCT01730469) | Amicus Therapeutics | 2011-08-01 |
| Neuroregenerative Potential of Intravenous G-CSF and Autologous Peripheral Blood Stem Cells (NCT02983708) | Hanyang University Seoul Hospital | 2011-08-01 |
| Evaluation of Liposomal Curcumin in Healthy Volunteers (NCT01403545) | SignPath Pharma, Inc. | 2011-08-01 |
| Study in Healthy Males to Assess the Bioavailability of 4 Different Fostamatinib Tablets (NCT01387308) | AstraZeneca | 2011-08-01 |
| To Assess the Bioequivalence of Brotizolam Tablets 250 Mcg vs. Lendormin Tablets 250 Mcg Administered to Healthy Adult Volunteers (NCT01361022) | Boehringer Ingelheim | 2011-08-01 |
| Pharmacokinetics of Favipiravir in Volunteers With Hepatic Impairment (NCT01419457) | MDVI, LLC | 2011-08-01 |
| XY-Zone Program Evaluation: A School-Based Dropout Prevention Program for At-Risk Youth (NCT01323231) | University of Texas at Austin | 2011-08-01 |
| Study for the Use of Alteplase in Patients Who Awaken With Stroke (NCT01150266) | University of California, San Diego | 2011-08-01 |
| Trial Evaluating the Safety and Pharmacokinetics of MFGR1877S in Patients With Advanced Solid Tumors (NCT01363024) | Genentech, Inc. | 2011-08-01 |
| Single Dose Study of GSK1440115 in Patients With Asthma (NCT01424280) | Accenture | 2011-08-01 |
| A Study to Evaluate a Single Intravenous (IV) Dose Using a New Manufactured Clone and Single Ascending Doses of Subcutaneous (SC) Injections (NCT02150070) | Astellas Pharma Global Development, Inc. | 2011-08-01 |
| A Single Dose Study of DWP10292 in Healthy Male Subjects (NCT01423526) | Daewoong Pharmaceutical Co. LTD. | 2011-08-01 |
| Effects of Anticholinergic or Long-Acting Beta 2 Agonist on FeNO and Pulmonary Function in SCI (NCT01355991) | James J. Peters Veterans Affairs Medical Center | 2011-08-01 |
| Antithrombin III Supplementation for Cardiopulmonary Bypass in Neonates (NCT01158729) | Medical College of Wisconsin | 2011-08-01 |
| HER2 PET Imaging in Breast Cancer Patients Using [68GA]ABY-025 (NCT02095210) | Dorte Nielsen | 2011-08-01 |
| A Multiple-Dose, Open-Label, Phase 1, Pharmacokinetic, Pharmacodynamic, and Safety Study of Avonex® in Chinese Healthy Volunteer Subjects (NCT01416207) | Biogen | 2011-08-01 |
| Trial of Neoadjuvant Short Course IMRT Followed by Surgery and IORT for Resectable Pancreatic Cancer (NCT01372735) | University Hospital Heidelberg | 2011-08-01 |
| Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS) (NCT01418001) | Memorial Sloan Kettering Cancer Center | 2011-08-01 |
| Fluoride Availability in Saliva After Use of Sodium Fluoride or Monofluorophosphate Toothpastes (NCT01589458) | University of Campinas, Brazil | 2011-08-01 |
| Safety and Pharmacokinetic Characteristics of HD203 Liq. in Healthy Subjects (NCT01431404) | Hanwha Chemical | 2011-08-01 |
| Integration of Neutron Therapy in the Treatment Plan for Stage III Non-Small Cell Lung Cancer (NSCLC) (NCT01416961) | Barbara Ann Karmanos Cancer Institute | 2011-08-01 |
| Oxytocin Modulation of Startle Reactivity to Social Stimuli and Moral Decision Making (NCT01607970) | University Hospital, Bonn | 2011-08-01 |
| A Study to Investigate How JNJ-39758979 May Affect the Plasma Levels of Methotrexate in Rheumatoid Arthritis Participants (NCT01442545) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2011-08-01 |
| Investigation of Ritonavir Effects on Afatinib Exposure in Healthy Subjects (NCT01426958) | Boehringer Ingelheim | 2011-08-01 |
| Research Involving Subjects With Parkinson's Disease, Alzheimer Disease and Healthy Controls (NCT01461109) | Institute for Neurodegenerative Disorders | 2011-08-01 |
| Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma (NCT01355705) | Michaela Liedtke | 2011-08-01 |
| Phase I and Pharmacokinetic Study of Mitoxantrone Hydrochloride Liposome Injection (NCT02043756) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2011-08-01 |
| A Feasibility and Safety Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic Cells in Patients With Metastatic, Locally Advanced, Unresectable, or Recurrent Pancreatic Adenocarcinoma (NCT01410968) | Carolyn Britten | 2011-08-01 |
| An Open Label Prostate Cancer Study in Japanese Patients (NCT01351688) | AstraZeneca | 2011-08-01 |
| A Double Blinded Study to Examine the Effect of Alpha Agonist Ointment on Fecal Incontinence in Patients With Idiopathic Fecal Incontinence (NCT01421823) | RDD Pharma Ltd | 2011-08-01 |
| A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of Warfarin (NCT01388335) | Eli Lilly and Company | 2011-08-01 |
| ABC294640 in Treating Patients With Advanced Solid Tumors (NCT01488513) | RedHill Biopharma Limited | 2011-08-01 |
| Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer (NCT01383343) | National Cancer Institute (NCI) | 2011-08-01 |
| A Study to Assess the Absorption, Metabolism and Excretion of Migalastat Hydrochloride (AT1001-014) (NCT01730482) | Amicus Therapeutics | 2011-08-01 |
| Pilot Imaging Study With 89Zr-Trastuzumab in HER2-positive Metastatic Breast Cancer Patients (NCT01420146) | Jules Bordet Institute | 2011-08-01 |
| Safety and Immunogenicity Study of a DNA Priming and MVA Boosting Strategy of HIV Vaccine (NCT01407497) | Instituto Nacional de Saúde, Mozambique | 2011-08-01 |
| Safety and Pharmacokinetics of SAR245408 Daily Oral in Patients With Solid Tumors (NCT01392924) | Sanofi | 2011-08-01 |
| Mesenchymal Stromal Cells as Treatment of Chronic Graft-versus-host Disease (NCT01522716) | Karolinska Institutet | 2011-08-01 |
| A Single Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-42165279 in Healthy Male Participants (NCT01650597) | Janssen-Cilag International NV | 2011-08-01 |
| Islet After Kidney Transplant for Type 1 Diabetes (NCT00784966) | Virginia Commonwealth University | 2011-08-01 |
| Study to Assess the Concentration of Avibactam and Ceftazidime in Epithelial Lining Fluid and Plasma (NCT01395420) | Pfizer | 2011-08-01 |
| A Study to Evaluate the Effect of Danoprevir/Ritonavir on the Pharmacokinetics of Escitalopram and S-Demethylcitalopram in Healthy Volunteers (NCT01418274) | Hoffmann-La Roche | 2011-08-01 |
| Study of Remote Ischemic Postconditioning (NCT01450475) | Xijing Hospital | 2011-08-01 |
| Safety & Tolerability Study of CTP-499 in Patients With Moderate Chronic Kidney Disease (NCT01460199) | Concert Pharmaceuticals | 2011-08-01 |
| Effects of Oral Mucolytics on Tear Film and Ocular Surface (NCT01713179) | Hallym University Kangnam Sacred Heart Hospital | 2011-08-01 |
| An Open Positron Emission Tomography Study to Assess the Effects of Varying Mass of AZD4694 on Radioligand Binding Parameters in Healthy Volunteers and Patients With Alzheimer's Disease (NCT01325402) | AstraZeneca | 2011-08-01 |
| Comparison of Postoperative Analgesic Effect of Intrathecal Clonidine and Fentanyl Added to Bupivacaine in Patients Undergoing Cesarean Section (NCT01425658) | Qazvin University Of Medical Sciences | 2011-08-01 |
| Bioequivalence And Food Effect Study Of Bosutinib In Healthy Subjects (NCT01374139) | Pfizer | 2011-08-01 |
| A Study to Evaluate the Effect of ASP1707 on the Bodies of Healthy Male Subjects After a Single Dose of Radioactive ASP1707 (NCT02106780) | Astellas Pharma Europe B.V. | 2011-08-01 |
| A PK and Safety Study in Subjects With Hepatic Impairment (NCT01431833) | Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2011-08-01 |
| Open-label Investigation of the Safety and Effectiveness of DIABECELL® in Patients With Type 1 Diabetes Mellitus (NCT01739829) | Diatranz Otsuka Limited | 2011-08-01 |
| Pilot Study of Hematopoietic Stem Cell Transplantation From Two Matched Sibling Donors in Treating Patients With Poor Prognosis Acute Leukemia and Advanced Lymphoproliferative Malignancies (NCT01385072) | Rabin Medical Center | 2011-08-01 |
| Dose-Escalation and Safety Study of APC-100 for the Treatment of Prostate Cancer (NCT01436214) | Adamis Pharmaceuticals Corporation | 2011-08-01 |
| A Study of Pioglitazone and Carboplatin in Patients With Advanced Solid Tumors (NCT02133625) | Dana-Farber Cancer Institute | 2011-08-01 |
| Vorinostat in Combination With Bortezomib, Doxorubicin and Dexamethasone (VBDD) in Patients With Refractory or Relapsed Multiple Myeloma (MM) (NCT01394354) | University Hospital Freiburg | 2011-08-01 |
| BI 836826 Dose Escalation in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) (NCT01403948) | Boehringer Ingelheim | 2011-08-01 |
| Safety Study of Repeated Dosing of a Cytotoxic Lymphocytes (CTL) Based Prostate Cancer Therapy (NCT01422850) | CytoVac A/S | 2011-08-01 |
| Hydroxychloroquine in Treating Patients With Solid Tumors Undergoing Radiation Therapy for Bone Metastases (NCT01417403) | Virginia Commonwealth University | 2011-08-01 |
| Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide (NCT01342289) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2011-08-01 |
| Dextromethorphan for Diabetic Macular Edema (NCT01441102) | National Eye Institute (NEI) | 2011-08-01 |
| Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects by Dermal Application of a LEO 29102 (NCT01423656) | LEO Pharma | 2011-08-01 |
| Safety Study Evaluating Twice-Daily Administration of Momelotinib in Primary Myelofibrosis or Post-Polycythemia Vera or Post-Essential Thrombocythemia Myelofibrosis (NCT01423058) | Sierra Oncology LLC - a GSK company | 2011-08-01 |
| Bioequivalence Study of Olanzapine Tablets, 5 mg of Dr. Reddy's Under Fasting Conditions (NCT01503398) | Dr. Reddy's Laboratories Limited | 2011-08-01 |
| In-vivo Regulatory T Cell Enhancement With Cyclophosphamide and Sirolimus (NCT01453140) | Hackensack Meridian Health | 2011-08-01 |
| Phase I Pharmacokinetic Study (BF-BLOCK) (NCT01423305) | Orion Corporation, Orion Pharma | 2011-08-01 |
| To Determine Blood Pressure Interaction Between TC-5214 and Anti-Hypertensive Medications (Calcium Channel Blockers, Beta Blockers, and ACE Inhibitors) in Patients With Chronic Hypertension (NCT01403922) | AstraZeneca | 2011-08-01 |
| Budesonide Application Via Mucosal Atomization Device as a Treatment for Chronic Rhinosinusitis When Utilized as a Topical Nasal Steroid Spray (NCT01405339) | St. Paul's Hospital, Canada | 2011-08-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Oral Doses of GLPG0634 in Healthy Subjects (NCT01419990) | Lakefront Biotherapeutics NV | 2011-08-01 |
| Immune Response of Individuals Vaccinated With Hypoallergenic Derivatives of the Major Birch Pollen Allergen, Bet v 1 (NCT01353924) | Medical University of Vienna | 2011-08-01 |
| A Study to Evaluate Skin Irritation and Photo Irritation of JNJ 10229570-AAA on Intact Skin of Japanese Healthy Male Participants (NCT01494714) | Janssen Pharmaceutical K.K. | 2011-08-01 |
| Oral Mucosal Absorption of ICI176,334-1 (NCT01415791) | AstraZeneca | 2011-08-01 |
| Interaction of Epanova on Warfarin Pharmacokinetic and Anticoagulant Activity and Comparison of the Effects of Epanova and Lovaza on Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) After Low-fat Meals (NCT01431690) | AstraZeneca | 2011-08-01 |
| Study in Healthy Volunteers to Establish the BioEquivalence of Two Formulations of BG00012 (NCT01420458) | Biogen | 2011-08-01 |
| A Clinical Trial Comparing Gemcitabine and Carboplatin With and Without P276-00 in Subjects With Metastatic Triple Negative Breast Cancer, With a Run-in of Escalating Dose of P276-00 Added to Gemcitabine and Carboplatin (NCT01333137) | Piramal Enterprises Limited | 2011-08-01 |